{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreigyhjsn6zbepz3nrcu5fog7fwhe5lfpffx4z2f2bxklitnnnyp6li",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mfpwv6jrda62"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreigvdwpfcscxkl4lhz62m4ghxafjuocbrcjg3tp3jdnwdslzsxuwxu"
    },
    "mimeType": "image/jpeg",
    "size": 410285
  },
  "path": "/news/2026-02-glp-drugs-combined-healthy-lifestyle.html",
  "publishedAt": "2026-02-25T18:30:04.000Z",
  "site": "https://medicalxpress.com",
  "tags": [
    "Cardiology"
  ],
  "textContent": "Individuals living with type 2 diabetes (T2D) had a significantly lower risk of poor cardiovascular health when they used a GLP-1 receptor agonist (GLP-1 RA) in combination with adhering to healthy lifestyle habits, according to a new study led by researchers at Harvard T.H. Chan School of Public Health and the Department of Veterans Affairs Boston Healthcare System.",
  "title": "GLP-1 drugs combined with healthy lifestyle habits linked to reduced cardiovascular risk among diabetes patients"
}